Health Care/Hospital

Menarini Silicon Biosystems to Host ESMO Symposium on Clinical Importance of Circulating Tumor Cells

World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer BOLOGNA, Italy and HUNTINGDON VALLEY, Pennsylvania, Sept. 23, 2019 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell tech...

2019-09-23 08:15 455

2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors

SUZHOU, China, Sept. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced results from the microsatellite instability high/deficient mismatch repair (MSI-H/dMMR) solid tumor cohort in the GEMSTONE-101 Phase Ib study of the Company's investigation...

2019-09-22 14:22 1262

2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab

SUZHOU, China, Sept. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced preliminary results from the Phase Ia trial of the Company's anti-CTLA-4 antibody in an oral presentation at the 22nd Annual Meeting of the Chinese Society of Clinical Onco...

2019-09-22 13:39 1412

2019 CSCO | CStone releases preliminary results from the Phase Ia trial of CS1003 in Chinese patients with advanced tumors

SUZHOU, China, Sept. 21, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today released the preliminary data from the Phase I bridging study of the Company's investigational anti-PD-1 monoclonal antibody CS1003 for the first time, in an oral presentation at the...

2019-09-21 00:26 1536

CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma

Not intended for US, Canada and UK-based media  * Opinion based on Phase III data showing combination lowered risk of disease progression or death by 31% and improved objective response rate compared with sunitinib[1] * Decision by the European Commission anticipated in fourth quarter of 2019...

2019-09-20 20:34 1489

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019

HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...

2019-09-20 19:00 11915

Nestle Displays Nutrition Innovation and Scientific Research Achievements and Wins Two Awards at the 14th China Nutrition Science Congress

NANJING, China, Sept. 20, 2019 /PRNewswire/ -- Nestle actively participated in the "14th China Nutrition Science Congress & the 11th Asia Pacific Conference on Clinical Nutrition and the 2nd Global Chinese Nutrition Scientists Conference" held fromSeptember 20 to 22, 2019 in Nanjing. The Organizi...

2019-09-20 16:53 3006

Combining Nature and Technology, Luye Medical and Cleveland Clinic Join to Build a Future Hospital in Shanghai

SHANGHAI, Sept. 20, 2019 /PRNewswire/ - Luye Medical and Cleveland Clinic today jointly presented an architectural scale model of the world's first Cleveland Clinic Connected project-the Shanghai Luye Lilan Hospital. Various leaders from the government agency ofShanghai's Minhang District and the...

2019-09-20 15:15 2883

Innovent Provides Update on Two Studies of IBI301 (Rituximab Biosimilar) in the Treatment of CD20-positive Lymphoma at Annual Meeting of CSCO

SUZHOU, China, Sept. 20, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, metabolic and other major diseases, announced today that the data for tw...

2019-09-20 14:30 7799

2019 CSCO | CStone announces promising trial data on its anti-PD-L1 antibody in esophageal squamous cell carcinoma with an ORR of 77.8%

SUZHOU, China, Sept. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced trial data from the esophageal squamous cell carcinoma (ESCC) cohort of a Phase Ib clinical trial of the Company's investigational anti-PD-L1 antibody CS1001 in an oral pre...

2019-09-19 23:48 1614

Advanced Aesthetic Technologies and China National Biotec Group Announce Strategic Cooperation

BROOKLINE, Massachusetts, Sept. 19, 2019 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, and China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM) today announced the execution of ...

2019-09-19 23:12 1954

Tresiba® Showed an Overall Lower Risk of Hypoglycaemia and Significantly Lower HbA1c When Compared to Insulin Glargine U300 in People With Type 2 Diabetes

BARCELONA, Spain, Sept. 19, 2019 /PRNewswire/ -- According to new data from the CONCLUDE head-to-head trial, Tresiba® (insulin degludec) showed an overall lower risk of hypoglycaemia, also known as a hypo or low blood sugar, at a significantly lower HbA1c, compared with insulin glargine U300 in a...

2019-09-19 18:01 1654

Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO

SUZHOU, China, Sept. 19, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, metabolic and other major diseases, announced today that the results of ...

2019-09-19 16:36 7332

Springer Publishing Company Moves Complete Journal Portfolio to ScholarOne

Nursing, medical, and behavioral sciences publisher will benefit from integrated peer review services from the Web of Science Group LONDON, Sept. 19, 2019 /PRNewswire/ -- The Web of Science Group, a Clarivate Analytics company, is proud to announce that Springer Publishing Company, the innovativ...

2019-09-19 15:00 5417

AXA Hack For Health, the First Health AI Hackathon in Hong Kong Now Open for Registration

HONG KONG, Sept. 19, 2019 /PRNewswire/ -- As an innovative insurer, AXA leverages Big Data and AI Technology Solutions to provide a superb experience to help their customers to live better lives. AXA aim to drive breakthrough advances in health and protection by supporting our customers in preven...

2019-09-19 14:23 2417

IDTechEx: The Future of Medical Is Wearables? (Part 2)

BOSTON, Sept. 19, 2019 /PRNewswire/ -- This is the second of a two part series exploring wearable medical devices. In part 1, IDTechEx discussed trends indicating that "the future of wearable is medical". In part 2, we explore the question in reverse, asking to what extent "the future of medical ...

2019-09-19 10:00 2379

RE:WELL REBELS launches its retreats and wellness programmes

SINGAPORE, Sept. 19, 2019 /PRNewswire/ -- RE:WELL REBELS is launching its first retreat at Hotel Fort Canning,Singapore from 1 to 3 November. People don't need to travel to an obscure location just to escape the hustle and bustle of the city. Thanks to RE:WELL REBELS, serenity is now just around ...

2019-09-19 09:30 1642

BookDoc, partners it's way to being Southeast Asia's Next Generation Healthcare Ecosystem is looking to raise Series A from Strategic partners

KUALA LUMPUR, Malaysia, Sept. 19, 2019 /PRNewswire/ -- BookDoc operates across the healthcare continuum connecting patients to healthcare professionals anytime, anywhere (Search & Book) with over 40,000 healthcare providers, brings healthcare to users fingertips (Tele-Consult), incentivizes users...

2019-09-19 09:00 1369

INEOS Styrolution to Exhibit at MEDTEC China in Shanghai in September 2019

* INEOS Styrolution's new Styroflex® 4G80 specifically designed for medical tubing applications on show * Broad range of innovative styrenic solutions for the healthcare industry * Consult with INEOS Styrolution's experts on selecting the best solution for  one's healthcare requirements SHANG...

2019-09-19 09:00 1596

Rodrigo Bianchi Appointed as New LimaCorporate Advisory Board Member

SAN DANIELE DEL FRIULI, Italy, Sept. 18, 2019 /PRNewswire/ -- LimaCorporate is pleased to announce thatRodrigo Bianchi will join the LimaCorporate Advisory Board. Rodrigo Bianchi is a Senior Global Executive in the Medical Device Industry with over 30 years of experience in some of the most impo...

2019-09-18 20:00 1634
1 ... 222223224225226227228 ... 437